The document provides an overview of Air Liquide's Q3 2022 activity, with the following key points:
- Sales growth of 8.3% in Q3 2022, driven by an 18% increase in IM pricing and strong performance across regions and business lines.
- Continued strong project signings and backlog, with over 40% of investment opportunities in energy transition.
- Resilient business model addressing high inflation and energy costs through price increases, efficiencies, and portfolio management.
- Guidance for 2022 confirmed, with confidence in further increasing margins and recurring profit growth.
Presentation accompanying the Quarterly Statement Q3 2022 call for investors and analysts on October 26, 2022
Full BASF Quarterly Statement Q3 2022 report available at https://basf.com/quarterlystatement
Presentation accompanying the Quarterly Statement Q3 2022 call for investors and analysts on October 26, 2022
Full BASF Quarterly Statement Q3 2022 report available at https://basf.com/quarterlystatement
Presentation accompanying the FY 2022 call for investors and analysts on February 24, 2023
Full BASF Report 2022 online available at https://basf.com/report
Presentation accompanying the Quarterly Statement 1st Quarter 2022 call for investors and analysts on April 29, 2022
Full BASF Quarterly Statement 1st Quarter 2022 online available at http://basf.com/quarterlystatement
Presentation accompanying the Half-Year 2022 call for investors and analysts on July 27, 2022
Full BASF Half-Year 2022 report available at http://basf.com/halfyearfinancialreport
Chief Executive Officer Alessandro Profumo presented on March 14th the FY2018 Results along with:
- Alessandra Genco - Chief Financial Officer
- Norman Bone - MD Electronics Division
- Gian PIero Cutillo - MD Helicopter Division
- Lucio Valerio Cioffi - MD Aircarft Division
- William J. "Bill" Lynn - CEO of Leonardo DRS
Get the financial highlights and an overview of our performance per business. You can view our financial reports here: www.sgs.com/en/our-company/investor-relations/reports-and-presentations
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
More Related Content
Similar to strong-sales-growth-solid-investment-momentum-illustrating-resilience-business-model-presentation.pdf
Presentation accompanying the FY 2022 call for investors and analysts on February 24, 2023
Full BASF Report 2022 online available at https://basf.com/report
Presentation accompanying the Quarterly Statement 1st Quarter 2022 call for investors and analysts on April 29, 2022
Full BASF Quarterly Statement 1st Quarter 2022 online available at http://basf.com/quarterlystatement
Presentation accompanying the Half-Year 2022 call for investors and analysts on July 27, 2022
Full BASF Half-Year 2022 report available at http://basf.com/halfyearfinancialreport
Chief Executive Officer Alessandro Profumo presented on March 14th the FY2018 Results along with:
- Alessandra Genco - Chief Financial Officer
- Norman Bone - MD Electronics Division
- Gian PIero Cutillo - MD Helicopter Division
- Lucio Valerio Cioffi - MD Aircarft Division
- William J. "Bill" Lynn - CEO of Leonardo DRS
Get the financial highlights and an overview of our performance per business. You can view our financial reports here: www.sgs.com/en/our-company/investor-relations/reports-and-presentations
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
1. Q3 2022 Activity - October 25, 2022
1
François Jackow, Chief Executive Officer
Jérôme Pelletan, Group Chief Financial Officer
Mike Graff, Executive Vice President
Pascal Vinet, Senior Vice President
Paris, October 25, 2022
Q3 2022 Activity
Strong Sales Growth
High Level of Project
Signings
2. Q3 2022 Activity - October 25, 2022
2 THIS DOCUMENT IS PUBLIC
Growth and Resilience
Well Positioned to Deliver Future Growth
François Jackow - Chief Executive Officer
01
3. Q3 2022 Activity - October 25, 2022
3 THIS DOCUMENT IS PUBLIC
Continued Strong Performance in Q3 2022
+18%
+8%
IM
Pricing
Comparable
Growth
Investment
Decisions
€1.1
bn
Cash Flow/
Sales(1)
24%
Q3 2022 figures
(1) Cash Flow from Operations before changes in WCR on Sales excluding energy pass through impact
4. Q3 2022 Activity - October 25, 2022
4 THIS DOCUMENT IS PUBLIC
Resilient Business Model Addressing the Current Challenges
IM pricing addressing spike in
energy price and inflation
100% Energy passthrough in LI
Q2 2021 Q3 2021 Q4 2021 Q1 2022 Q2 2022 Q3 2022
>€1.4
bn
~€1bn
~€0.9bn
Energy impact
2019 2020 2021 2022
European Natural Gas price - NL-TTF (€/MWh) Quarterly energy passthrough impact on LI sales
■ Strong contracts,
fixed revenue from rentals
■ Diversity of business reach ■ Energy transition, EL & HC ■ Performance focused
A reinforced resilient business model
Inflation (Source: Consensus Forecast) IM Pricing
€/MWh €m
FY 21
~€1.7
bn
5. Q3 2022 Activity - October 25, 2022
5 THIS DOCUMENT IS PUBLIC
Well Positioned to Deliver Future Growth
€3.4bn
Strong &
Diversified
Backlog
>€2.5bn of investment in
Electronics over 4 years(1)
(1) Investment decisions since Q4 2018
Already 6 projects selected for
European/national subsidies
Lime plant
Normand’Hy
200 MW
K6 - Cement plant
Kairos@C
CurtHyl
200 MW
ELYgator
200 MW
Electrolysis
Carbon
Capture
6. Q3 2022 Activity - October 25, 2022
6 THIS DOCUMENT IS PUBLIC
Strong Sales Growth
Active Projects Signing and Strong Backlog
Jérôme Pelletan - Chief Financial Officer
02
7. Q3 2022 Activity - October 25, 2022
7 THIS DOCUMENT IS PUBLIC
Impacts on Q3 Group Sales:
Continued Strong Sales Growth
Sales in €m Q3 21 Q3 22 Q3 22/21
As published
Q3 22/21
Comparable
YTD 22/21
Comparable
Gas & Services 5,585 7,897 +41.4% +7.2% +7.2%
Engineering &
Construction
81 115 +41.1% +37.3% +31.7%
Global Markets &
Technologies
168 235 +39.5% +32.7% +20.3%
Group Total 5,834 8,247 +41.3% +8.3% +7.9%
+24.4% Energy -0.2% Significant Scope
+8.8% FX
(1) Impact on sales of all acquisitions or disposals of a significant size for the Group
(1)
8. Q3 2022 Activity - October 25, 2022
8 THIS DOCUMENT IS PUBLIC
▪ Volumes -6%
▪ Weak Steel and Chemicals
▪ Lower H2
demand in Refineries
▪ Accelerating pricing ~+30%
▪ Slight volume growth
▪ Strong momentum in HHC driven by diabetes
▪ Lower O2
for covid-19, higher pricing
▪ Start-ups contributing to robust air gases volumes
▪ Strong H2
sales in Latam, turnarounds in U.S.
▪ Higher pricing >+16%
▪ +2% volumes excluding helium
▪ Lower O2
for covid-19 across the region
▪ Strong proximity care in U.S.
▪ Improving Latam
▪ High Carrier Gases, ESM(1)
and E&I
High growth across all activities
Record high IM pricing, low demand in LI, strong HC
Q3 – Strong Americas, Mixed Europe
● LI
Americas
Europe
G&S comparable sales growth (1) Electronic Specialty Materials
Sales
Q3 2022
€2,936m
Sales
Q3 2022
€3,266m
● IM
● HC
● EL
● LI
● IM
● HC
FY 21: +7.6%
FY 21: +7.0% YTD 22: +4.1%
YTD 22: +10.5%
9. Q3 2022 Activity - October 25, 2022
9 THIS DOCUMENT IS PUBLIC
▪ China +9%
▪ Low demand in rest of Asia
▪ Pricing >+9%
▪ Improving volumes
▪ High China, driven by pricing and small acquisitions
▪ >+20% growth in Carrier Gases, ESM(1)
and E&I
▪ Strong sales in India and Egypt
▪ Small divestitures in Middle-East
▪ Reduced O2
sales for covid-19
Q3 – Strong Asia driven by Electronics, Solid AMEI
● LI
● IM
● LI
● IM
● HC
Sales
Q3 2022
€1,474m
● EL
Sales
Q3 2022
€221m
Buoyant EL, accelerating IM pricing over the region
Asia
AMEI
G&S comparable sales growth (1) Electronic Specialty Materials
Steady LI, low IM & HC
FY 21: +6.4%
FY 21: +12.7% YTD 22: +0.1%
YTD 22: +7.3%
10. Q3 2022 Activity - October 25, 2022
10 THIS DOCUMENT IS PUBLIC
● Overall volumes -2%
[see appendix for combined effect]
● Robust air gases volumes in Americas and China
● Slowing demand in Europe
● Solid contribution from start-ups and ramp-ups
Industrial Merchant Large Industries
Q3 – Pursued Momentum in Industrial Merchant, Mixed Large Industries
G&S comparable sales growth
Sales
Q3 2022
€3,112m
FY 21: +5.5%
Strong Americas and solid Asia offset by slowing Europe
Record pricing, resilient volumes
● Record +18% pricing, successfully addressing
unprecedented spike in energy cost and high inflation
● Growing volumes offset by helium
● Strong Food & Beverage, Robust Materials & Energy,
improving Auto
Sales
Q3 2022
€3,092m
FY 21: +8.4% YTD 22: +14.5% YTD 22: -4.8%
11. Q3 2022 Activity - October 25, 2022
11 THIS DOCUMENT IS PUBLIC
Electronics
Q3 – Buoyant Electronics, Very Robust Healthcare
● Normalizing Medical O2
volumes after covid-19
● Strong Home Healthcare driven by diabetes
● High Specialty Ingredients
● Increasing pricing in all regions
Strong Home Healthcare
Healthcare
Sales
Q3 2022
€999m
FY 21: +7.2%
Sales
Q3 2022
€694m
Continued strong momentum in all segments
● >+21% growth in Carrier Gases, ESM(1)
and E&I
● Continued development of Advanced Materials
● Significant contribution from start-ups and ramp-ups
● High pricing in ESM(1)
driven by rare gases
FY 21: +7.0%
G&S comparable sales growth (1) Electronic Specialty Materials
YTD 22: +3.1%
YTD 22: +17.4%
12. Q3 2022 Activity - October 25, 2022
12 THIS DOCUMENT IS PUBLIC
+18%
-10%
Strong Comparable Growth supported by Geographic and Business Mix
+5%
+21%
by Activities
Q3 2022 Gas & Services comparable sales growth
Group Comparable sales growth +8%
Europe
0%
Middle-East
Africa
-1%
Asia-Pacific
+11%
Americas
+13%
13. Q3 2022 Activity - October 25, 2022
13 THIS DOCUMENT IS PUBLIC
2016 2017 2018 2019 2020
▪ Pursued acceleration in pricing
▪ Successful price management in all
geographies to address inflation
▪ Strong focus on operational
efficiencies
▪ Procurement contribution limited
by high inflation
Performance Focused in an Inflationary Environment
€262m
€400m
YTD Q3 2022
(1) Cash Flow from Operations before changes in Working Capital Requirements on Group sales excluding energy passthrough impact
Cash Flow to Sales
24%
(1)
IM Pricing Efficiencies
+18.0%
Portfolio Management
2021 2022
4 divestitures YTD
Middle-East
Mexico
U.S., Netherlands, China
China
12 acquisitions YTD
U.S., South Africa
14. Q3 2022 Activity - October 25, 2022
14 THIS DOCUMENT IS PUBLIC
Americas
Europe
Asia-Pacific
Middle-East & Africa
Total
Industrial Merchant
Accelerating IM Pricing
Effective Management of Spike in Energy Cost & Inflation
Q3 2022
YTD 2022
Pricing Actions
▪ Contractual indexations
▪ Strengthened price management
to address high energy price and
inflation
Cylinders
▪ Targeted actions to address
inflationary environment
Bulk
+18.0%
15. Q3 2022 Activity - October 25, 2022
15 THIS DOCUMENT IS PUBLIC
High signing activity in Q3:
▪ Strong in EL, major projects in Taiwan
▪ Dynamic in Energy Transition
■ IM oxycombustion
■ Biogas
■ Sasol ASUs efficiency program
■ ASUs electrification in China
Active Projects Signing and Strong Backlog
Sustained level of investment
opportunities:
▪ >40% in Energy Transition
▪ Well-balanced by geographies
(1) See definitions in appendix (2) Russian projects have been removed from Q3 2022 Backlog
Investment Opportunities (1)
Investment Decisions (1)
Strong Backlog:
▪ Many projects in EL,
especially in Asia
€1.3bn of yearly sales after
full ramp-up
Investment Backlog (1)
Financial Industrial
(2)
>€3.0bn
16. Q3 2022 Activity - October 25, 2022
16 THIS DOCUMENT IS PUBLIC
YTD
Q3 2022
€288m
FY 2022
Guidance
€400
-
425m
(1) Including the additional contribution from Sasol ASUs takeover accounted for in Significant Perimeter (€+72m YTD 2022; estimated at €+135m for FY 2022) and excluding
ramp-ups in Russia from September 2022. At constant exchange rate and excluding energy passthrough impact
Significant SU and RU Contribution to Sales
Start-up date of major projects
Start-up/Ramp-up
Sales Contribution(1)
Large Industries Electronics GM&T
2022
Q1 Q2 Q3 Q4
2023
Asia
Asia Asia
US US
Europe Asia
US
Europe Europe
17. Q3 2022 Activity - October 25, 2022
17 THIS DOCUMENT IS PUBLIC
Confirmed 2022 Guidance
(1) Operating margin excluding energy passthrough impact. Recurring net profit excluding exceptional and significant transactions that have no impact on the operating
income recurring, and excluding the impact of any US tax reform in 2022
Assuming no significant economic disruption,
Air Liquide is confident in its ability
to further increase its operating margin
and to deliver recurring net profit growth,
at constant exchange rates.(1)
18. Q3 2022 Activity - October 25, 2022
18 THIS DOCUMENT IS PUBLIC
Appendix
03
19. Q3 2022 Activity - October 25, 2022
19 THIS DOCUMENT IS PUBLIC
Large
Industries
Europe
Combined Effect
Salesn-1
Volume
Energy Price
Volume
Energy
Impact
Combined
Included in
Comparable Sales
Included in
Comparable Sales
Typical
price
variation
Pn
Pn-1
Non-significant
combined effect
Pn
Pn-1
Significant
price
variation
V V
Vn
Vn-1
Sn
= Pn
* Vn
Vn-1
Vn
P
P
Sn
= Pn
* Vn
Excluded from
Comparable Sales
Positive energy impact
Positive volume
impact
-6% volume impact
Negative
combined
effect
“Normal” case Exceptional Q3 2022 case
Positive energy impact
20. Q3 2022 Activity - October 25, 2022
20 THIS DOCUMENT IS PUBLIC
Gas & Services
Revenue
€7,897m
Americas
37%
Europe
41%
Asia-Pacific
19%
Africa
Middle-East
3%
Q3 2022 G&S Revenue Breakdown by Region
5% 2%
34%
64%
22%
28%
22%
56% 35%
9% 20%
3%
Americas
€2.9bn
Europe
€3.3bn Asia-Pacific
€1.5bn
Africa
Middle-East
€0.2bn
32%
62%
6%
Large Industries Electronics
Healthcare
Industrial Merchant
21. Q3 2022 Activity - October 25, 2022
21 THIS DOCUMENT IS PUBLIC
Maintained Strong Base Business, Significant SU/RU Contribution
See definitions in appendix
+5.7%
Base
business
Breakdown of G&S Sales Growth
+12.6%
2019 2020 2021
Significant M&A
Base business
Start-ups, Ramp-ups, Site takeovers
2022
22. Q3 2022 Activity - October 25, 2022
22 THIS DOCUMENT IS PUBLIC
Q3 - Americas
▪ Strong contribution from
Carrier Gases
▪ High ESM(1)
and E&I
▪ Start-ups contributing to
robust air gases volumes in
Chemicals, softening demand
in Steel
▪ Strong H2
sales in Latam
from ramp-ups, turnarounds
in U.S.
▪ Strong cogen, especially in
Canada
▪ Lower Medical O2
for
covid-19 across the region
▪ Strong Proximity Care in U.S.
with high pricing
▪ Improving Latam: dynamic
HHC, Medical gases back to
positive contribution
Industrial Merchant Large Industries Healthcare Electronics
5%
Sales
Q3 2022
€2,936m 64%
22%
9%
Q3 22/21 Comparable Growth: +12.8%
(1) Electronic Specialty Materials
▪ Higher pricing +16.1%
▪ +2% volumes excluding
helium, in particular in bulk
and hardgoods
▪ End-markets well oriented,
in particular Auto, Food,
Fabrication and Energy
23. Q3 2022 Activity - October 25, 2022
23 THIS DOCUMENT IS PUBLIC
Q3 - Europe
▪ Record high pricing +29.9% to address
high Energy price and inflation
▪ Slight daily volume growth, notably in
cylinders
▪ Sales growth in all end-markets, with
slight volume increase in Food,
Fabrication and Materials
▪ Volumes -6%
[see appendix for combined effect]
▪ Weak Steel and Chemicals
▪ Lower H2
demand in Refineries, using
lighter crude oil
▪ Strong momentum in HHC driven by
diabetes
▪ Lower O2
volumes related to Covid-19
▪ High Speciality Ingredients
▪ Improving pricing
Industrial Merchant Large Industries Healthcare
Q3 22/21 Comparable Growth: -0.2%
Sales
Q3 2022
€3,266m
56%
2%
20% 22%
-27.5%
Combined effect
24. Q3 2022 Activity - October 25, 2022
24 THIS DOCUMENT IS PUBLIC
Q3 - Asia-Pacific
(1) Dual Energy Control (2) Electronic Specialty Materials
▪ Increased pricing across the region
+9.3%
▪ High China, driven by pricing and small
acquisitions
▪ Solid Automotive, Technology, Energy
and Food, especially in China
▪ All segments contributing to growth,
>+20% in Carrier Gases, ESM(2)
and E&I
▪ High pricing in ESM(2)
driven by rare
gases
▪ Strong Advanced Materials, notably in
Singapore and China
Electronics
Sales
Q3 2022
€1,474m
28%
35%
34%
3%
Q3 22/21 Comparable Growth: +10.9%
Industrial Merchant Large Industries
▪ China +9%, driven by solid air gases
vs. DEC(1)
impact in Q3 2021
▪ Low demand in rest of Asia, notably air
gases for Steel in Japan and H2
for
Chemicals in Korea
25. Q3 2022 Activity - October 25, 2022
25 THIS DOCUMENT IS PUBLIC
Solid order intake
vs. high Q3 21
Q3 - Solid E&C, Strong GM&T Driven by Biogas
€169m -44%
€108m
Total Sales(1)
in Q3 22 +29%
(1) Including internal sales
Comparable sales growth
€243m +31%
€189m
Engineering & Construction Global Markets & Technologies
Comparable sales growth
Sales
Q3 2022
€115m
Sales
Q3 2022
€235m
Strong order intake,
led by Turbo Braytons
and Biogas equipment
26. Q3 2022 Activity - October 25, 2022
26 THIS DOCUMENT IS PUBLIC
Strong and Diversified Backlog at €3.4bn
Start-ups
Decisions
See definitions in appendix (1) Russian projects have been removed from Q3 2022 Backlog
€1.3bn
Yearly Sales
Backlog
after full
Ramp-ups
(1)
28. Q3 2022 Activity - October 25, 2022
28 THIS DOCUMENT IS PUBLIC
Financing Structure as of June 30, 2022
Variable
rate
16%
Fixed
rate
84%
Bank debt
10%
Commercial
paper
12%
Private
placements
9%
Bonds
68%
Others(1)
1%
Market debt
89%
(1) Others: put options granted to minority shareholders (2) Higher commercial papers at variable rate: short term financing expected to be mostly reimbursed before year end 2022
< 1 year
> 5 years
Between 1 and
5 years
€m
15,000
10,000
5,000
0
Sources Maturity
Fixed / Variable rates
(gross debt)
(2)
(2)
29. Q3 2022 Activity - October 25, 2022
29 THIS DOCUMENT IS PUBLIC
Investment Cycle – Definitions
Investment opportunities at end of the period
▪ Investment opportunities under consideration by the Group for decision within 12 months.
▪ Industrial projects with investment value > €5m for Large Industries and > €3m for other business lines.
▪ Includes asset replacements or efficiency projects. Excludes maintenance and safety.
Investment backlog at end of the period
▪ Cumulated industrial investment value of projects decided but not yet started.
▪ Industrial projects with value > €10m, including asset replacements or efficiency projects, excluding maintenance
and safety.
Sales backlog
▪ Cumulated expected sales per year generated by the current investment backlog after full ramp-up.
Decisions of the period
▪ Cumulated value of industrial and financial investment decisions.
▪ Industrial, growth and non-growth projects including asset replacements, efficiency, maintenance and safety.
▪ Financial decisions (acquisitions).
30. Q3 2022 Activity - October 25, 2022
30 THIS DOCUMENT IS PUBLIC
Regular and Sustained performance
CAGR over 30 years(1)
Revenue (in €m)
+5.4%
Cash Flow (in €m)
+5.9% +8.3%
+6.7%
EPS (2)
(in €)
Dividend (2)
(in € per share)
(1) Calculated according to prevailing accounting rules over 30 years
(2) Adjusted for the 2-for-1 share split in 2007, for free share attributions and for the capital increase completed in October 2016
31. Q3 2022 Activity - October 25, 2022
31 THIS DOCUMENT IS PUBLIC
For further information, please contact:
www.airliquide.com
Follow us on Twitter @AirLiquideGroup
Investor Relations
IRTeam@airliquide.com
Phone: +33 (0)1 40 62 51 50
Communication
Media@airliquide.com
Phone: +33 (0)1 40 62 58 49
L’Air Liquide S.A.
Corporation for the study and application of processes developed by
Georges Claude with registered capital of 2,878,025,870.50 euros
Upcoming events
2022 Full Year Results: February 16, 2023
Corporate Headquarters:
75, Quai d’Orsay
75321 Paris Cedex 07
Tel : +33 (0)1 40 62 55 55
RCS Paris 552 096 281
32. Q3 2022 Activity - October 25, 2022
32 THIS DOCUMENT IS PUBLIC
Disclaimer
This presentation may contain forward-looking statements (including objectives and trends) about Air Liquide’s
financial situation, operating results, business activities and strategy.
Although Air Liquide believes that the expectation reflected in such forward-looking statements are reasonable, such
statements are not guarantees of future performance. Actual results may differ materially from the forward-looking
statements as a result of a number of risks and uncertainties, many of which are outside our control.
Please refer to the most recent Universal Registration Document filed by Air Liquide with the French Autorité des
marchés financiers for additional information in relation to such risks and uncertainties.
The information is valid only at the time of writing and Air Liquide does not assume any obligation to update or
revise the objectives on the basis of new information or future or other events, subject to applicable regulations.